Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Sign in
Sign in

Takeda and Crescendo Biologics enter into cancer drug development partnership

Takeda Pharmaceutical Company Limited and Crescendo Biologics Limited said early Monday they entered into a cancer drug development partnership worth up to $36 million and as much as $754 million in additional milestone payments. The collaboration's focus is on using Crescendo's Humabody-based drugs for cancers with a high unmet medical need, the companies said.

Crescendo is eligible for up to $36 million under the deal, which includes an upfront payment, investment, research funding and preclinical milestones, and further milestone payments of $754 million.

The agreement grants Takeda development and commercial rights to the collaboration's Humabody-based treatments, for which Crescendo is eligible for royalties on product sales. Crescendo Chief Executive Officer Dr. Peter Pack called the partnership, its first major one, a "validation of our transgenic platform."

Takeda shares rose 14.4% over the last three months, compared with a 1.1% rise in the S&P 500 SPX, -0.56%

By Emma Court  Reporter

Published: Oct 10, 2016

Source: http://www.marketwatch.com/

0
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies